메뉴 건너뛰기




Volumn 63, Issue 2, 2009, Pages 264-270

Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States

Author keywords

Lung cancer; NSCLC; Predictor; SEER; Treatment; Trend

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEFITINIB; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN; NAVELBINE; PACLITAXEL; PEMETREXED; TAXANE DERIVATIVE; VINBLASTINE;

EID: 58049219901     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.05.003     Document Type: Article
Times cited : (52)

References (22)
  • 1
    • 33747607482 scopus 로고    scopus 로고
    • Clinical practice guidelines in oncology
    • Non-small cell lung cancer
    • Non-small cell lung cancer. Clinical practice guidelines in oncology. JNCCN 4 6 (2006) 548-582
    • (2006) JNCCN , vol.4 , Issue.6 , pp. 548-582
  • 2
    • 0026759013 scopus 로고
    • New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification
    • Bulzebruck H., Bopp R., Drings P., Bauer E., Krysa S., Probst G., et al. New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer 70 5 (1992) 1102-1110
    • (1992) Cancer , vol.70 , Issue.5 , pp. 1102-1110
    • Bulzebruck, H.1    Bopp, R.2    Drings, P.3    Bauer, E.4    Krysa, S.5    Probst, G.6
  • 3
    • 0023922084 scopus 로고
    • Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial
    • Rapp E., Pater J.L., Willan A., Cormier Y., Murray N., Evans W.K., et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 6 4 (1988) 633-641
    • (1988) J Clin Oncol , vol.6 , Issue.4 , pp. 633-641
    • Rapp, E.1    Pater, J.L.2    Willan, A.3    Cormier, Y.4    Murray, N.5    Evans, W.K.6
  • 4
    • 0025735389 scopus 로고
    • A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study
    • Weick J.K., Crowley J., Natale R.B., Hom B.L., Rivkin S., Coltman C.A., et al. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 9 7 (1991) 1157-1162
    • (1991) J Clin Oncol , vol.9 , Issue.7 , pp. 1157-1162
    • Weick, J.K.1    Crowley, J.2    Natale, R.B.3    Hom, B.L.4    Rivkin, S.5    Coltman, C.A.6
  • 5
    • 58049199286 scopus 로고    scopus 로고
    • Non-small Cell Lung Cancer Collaborative Group: chemotherapy for non-small cell lung cancer. The Cochrane Library, 2000, Issue 2. http://gateway.ut.ovid.com.proxy.medlib.iupui.edu/gw1/ovidweb.cgi.
    • Non-small Cell Lung Cancer Collaborative Group: chemotherapy for non-small cell lung cancer. The Cochrane Library, 2000, Issue 2. http://gateway.ut.ovid.com.proxy.medlib.iupui.edu/gw1/ovidweb.cgi.
  • 6
    • 0037050352 scopus 로고    scopus 로고
    • Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
    • Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 2 (2002) 92-98
    • (2002) N Engl J Med , vol.346 , Issue.2 , pp. 92-98
    • Schiller, J.H.1    Harrington, D.2    Belani, C.P.3    Langer, C.4    Sandler, A.5    Krook, J.6
  • 7
    • 23844515641 scopus 로고    scopus 로고
    • A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): update of the alpha oncology trial (A1-99002L)
    • Treat J., Belani C.P., Edelman M.J., Socinski M.A., Ansari R.H., Obassaju C.K., et al. A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): update of the alpha oncology trial (A1-99002L). J Clin Oncol 23 16S (2005) 7025
    • (2005) J Clin Oncol , vol.23 , Issue.16 S , pp. 7025
    • Treat, J.1    Belani, C.P.2    Edelman, M.J.3    Socinski, M.A.4    Ansari, R.H.5    Obassaju, C.K.6
  • 8
    • 4344670233 scopus 로고    scopus 로고
    • Population variation in the initial treatment of non-small-cell lung cancer
    • Potosky A.L., Saxman S., Wallace R.B., and Lynch C.F. Population variation in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22 16 (2004) 3261-3268
    • (2004) J Clin Oncol , vol.22 , Issue.16 , pp. 3261-3268
    • Potosky, A.L.1    Saxman, S.2    Wallace, R.B.3    Lynch, C.F.4
  • 9
    • 14644396447 scopus 로고    scopus 로고
    • Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from Surveillance, Epidemiology and End Results-Medicare
    • Ramsey S.D., Howlader N., Etzioni R.D., and Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from Surveillance, Epidemiology and End Results-Medicare. J Clin Oncol 22 24 (2004) 4971-4978
    • (2004) J Clin Oncol , vol.22 , Issue.24 , pp. 4971-4978
    • Ramsey, S.D.1    Howlader, N.2    Etzioni, R.D.3    Donato, B.4
  • 11
    • 0032212492 scopus 로고    scopus 로고
    • A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort
    • Hillner B.E., McDonald M.K., Desch C.E., Smith T.H., Penberthy L.T., Rechin S.M., et al. A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort. Cancer 83 (1998) 1930-1937
    • (1998) Cancer , vol.83 , pp. 1930-1937
    • Hillner, B.E.1    McDonald, M.K.2    Desch, C.E.3    Smith, T.H.4    Penberthy, L.T.5    Rechin, S.M.6
  • 12
    • 58049205307 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Drugs@FDA. FDA approved drug products. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Search_Drug_Name [accessed 17.05.07].
    • U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Drugs@FDA. FDA approved drug products. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Search_Drug_Name [accessed 17.05.07].
  • 13
    • 58049216966 scopus 로고    scopus 로고
    • National Cancer Institute (NCI): SEER-Medicare Publications, 2005. http://healthservices.cancer.gov/seermedicare/overview/publications.html.
    • National Cancer Institute (NCI): SEER-Medicare Publications, 2005. http://healthservices.cancer.gov/seermedicare/overview/publications.html.
  • 14
    • 33845961014 scopus 로고    scopus 로고
    • Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    • Shih T., and Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28 11 (2006) 1779-1802
    • (2006) Clin Ther , vol.28 , Issue.11 , pp. 1779-1802
    • Shih, T.1    Lindley, C.2
  • 16
    • 28044438900 scopus 로고    scopus 로고
    • How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care
    • Kris M.G. How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care. Oncologist 10 Suppl. 2 (2005) 23-29
    • (2005) Oncologist , vol.10 , Issue.SUPPL. 2 , pp. 23-29
    • Kris, M.G.1
  • 17
    • 7144229342 scopus 로고    scopus 로고
    • First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study
    • Georgoulias V., Androulakis N., Dimopoulos A.M., Kourousis C., Kakolyris S., Papadakis E., et al. First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study. Ann Oncol 9 3 (1998) 331-334
    • (1998) Ann Oncol , vol.9 , Issue.3 , pp. 331-334
    • Georgoulias, V.1    Androulakis, N.2    Dimopoulos, A.M.3    Kourousis, C.4    Kakolyris, S.5    Papadakis, E.6
  • 18
    • 33745632406 scopus 로고    scopus 로고
    • A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
    • Booton R., Lorigan P., Anderson H., Baka S., Ashcroft L., Nicolson M., et al. A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1). Ann Oncol 17 7 (2006) 1111-1119
    • (2006) Ann Oncol , vol.17 , Issue.7 , pp. 1111-1119
    • Booton, R.1    Lorigan, P.2    Anderson, H.3    Baka, S.4    Ashcroft, L.5    Nicolson, M.6
  • 19
    • 0036810227 scopus 로고    scopus 로고
    • Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
    • Rosell R., Gatzemeier U., Betticher D.C., Keppler U., Macha H.N., Pirker R., et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol 13 10 (2002) 1539-1549
    • (2002) Ann Oncol , vol.13 , Issue.10 , pp. 1539-1549
    • Rosell, R.1    Gatzemeier, U.2    Betticher, D.C.3    Keppler, U.4    Macha, H.N.5    Pirker, R.6
  • 20
    • 0346560025 scopus 로고    scopus 로고
    • Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975
    • Smit E.F., van Meerbeeck J.P., Lianes P., Debruyne C., Legrand C., Schramel F., et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 21 21 (2003) 3909-3917
    • (2003) J Clin Oncol , vol.21 , Issue.21 , pp. 3909-3917
    • Smit, E.F.1    van Meerbeeck, J.P.2    Lianes, P.3    Debruyne, C.4    Legrand, C.5    Schramel, F.6
  • 21
    • 17344384668 scopus 로고    scopus 로고
    • Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
    • Sandler A.B., Nemunaitis J., Denham C., von Pawel J., Cormier Y., Gazemeier U., et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18 1 (2000) 122-130
    • (2000) J Clin Oncol , vol.18 , Issue.1 , pp. 122-130
    • Sandler, A.B.1    Nemunaitis, J.2    Denham, C.3    von Pawel, J.4    Cormier, Y.5    Gazemeier, U.6
  • 22
    • 0042661285 scopus 로고    scopus 로고
    • Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in Stage IIIb and IV non-small cell lung cancer: a phase III randomized trial
    • Zatloukal P., Petruzelka L., Zemanova M., Kolek V., Skrickova J., Pesek M., et al. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in Stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. Lung Cancer 41 3 (2003) 321-331
    • (2003) Lung Cancer , vol.41 , Issue.3 , pp. 321-331
    • Zatloukal, P.1    Petruzelka, L.2    Zemanova, M.3    Kolek, V.4    Skrickova, J.5    Pesek, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.